Présentation scientifique
Expérience avec ZEISS SLT en tant que traitement d'appoint
Le Dr Karsten Klabe présente les résultats de l'étude lors de la ZEISS Parallel Industry Session au 15ème congrès de l'EGS
7 octobre 2022
· 10 MIN VISIONNAGE
![Dr Karsten Klabe, chirurgien en chef, Breyer, Kaymak & Klabe Augenchirurgie]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.100.100.579,501,1564,1486.file/klabe_01_mai_2018.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.360.360.579,501,1564,1486.file/klabe_01_mai_2018.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.768.768.579,501,1564,1486.file/klabe_01_mai_2018.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.985.985.579,501,1564,1486.file/klabe_01_mai_2018.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.985.985.579,501,1564,1486.file/klabe_01_mai_2018.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.985.985.579,501,1564,1486.file/klabe_01_mai_2018.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1324-experience-with-zeiss-slt-as-adjunctive-therapy-dr-klabe/klabe_01_mai_2018.jpg/_jcr_content/renditions/original.image_file.985.985.579,501,1564,1486.file/klabe_01_mai_2018.jpg"} "Dr Karsten Klabe, chirurgien en chef, Breyer, Kaymak & Klabe Augenchirurgie")
Auteur
Dr Karsten Klabe
Chirurgien en chef, Breyer, Kaymak & Klabe Augenchirurgie
Résumé
Investigation clinique prospective et multicentre visant à évaluer la sûreté et l'efficacité de Selective Laser Trabeculoplasty (SLT) de ZEISS VISULAS green.
La finalité de cette étude était d'évaluer la sûreté et l'efficacité de Selective Laser Trabeculoplasty (SLT) avec le laser VISULAS green pour réduire la pression intraoculaire (IOP) chez des patients atteints de glaucome primitif à angle ouvert (POAG). L'étude a été réalisée avec VISULAS green doté de l'option SLT dans cinq centres de recherche en Allemagne.
Les résultats indiquent que VISULAS green a démontré une efficacité significative sur le plan clinique pour réduire l'IOP d'yeux atteints de POAG. Ces résultats sont comparables à ceux obtenus avec d'autres dispositifs SLT et la différence par rapport aux valeurs de référence en matière de réduction de l'IOP est significative d'un point de vue statistique.
![L'intérêt de l'analyse de l'évolution pour la prise en charge des patients sur le long terme]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original.image_file.100.56.file/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original.image_file.360.203.file/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original.image_file.768.432.file/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original./1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original./1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original./1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1288-value-of-progression-analysis-for-long-term-patient-management-dr-casas-de-llera/1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg/_jcr_content/renditions/original./1288-en-int_31_160_0406i-value_of_progression_analysis_in_patient_management_teaser.jpg"} "L'intérêt de l'analyse de l'évolution pour la prise en charge des patients sur le long terme")
![SITA Faster et 24-2C, pratique et perspectives]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original.image_file.100.56.file/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original.image_file.360.203.file/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original.image_file.768.432.file/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original.image_file.1024.576.file/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original./1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original./1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1287-sita-faster-and-24-2c-practice-and-perspectives-dr-moreno/1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg/_jcr_content/renditions/original./1287-en-int_31_160_0408i-sita_faster_and_24-2c_practice_and_perspectives_teaser.jpg"} "SITA Faster et 24-2C, pratique et perspectives")
![Prise en charge du glaucome à l'aide de SITA Faster et 24-2C – Dr Oddone]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original.image_file.100.56.file/1284-en-int-31-160-0410-glaucoma-management.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original.image_file.360.203.file/1284-en-int-31-160-0410-glaucoma-management.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original.image_file.768.432.file/1284-en-int-31-160-0410-glaucoma-management.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original.image_file.1024.576.file/1284-en-int-31-160-0410-glaucoma-management.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original./1284-en-int-31-160-0410-glaucoma-management.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original./1284-en-int-31-160-0410-glaucoma-management.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1284-glaucoma-management-using-sita-faster-and-24-2c-dr-oddone/1284-en-int-31-160-0410-glaucoma-management.jpg/_jcr_content/renditions/original./1284-en-int-31-160-0410-glaucoma-management.jpg"} "Prise en charge du glaucome à l'aide de SITA Faster et 24-2C – Dr Oddone")